Involvement of the Immune System in Airways Disease

[1]  C. Bachert,et al.  A substantial neutrophilic inflammation as regular part of severe type 2 chronic rhinosinusitis with nasal polyps. , 2020, The Journal of allergy and clinical immunology.

[2]  C. Bachert,et al.  Type 2 Inflammation in Chronic Rhinosinusitis without Nasal Polyps: Another Relevant Endotype. , 2020, The Journal of allergy and clinical immunology.

[3]  M. Dogan,et al.  Increased TSLP, IL-33, IL-25, IL-19, IL 21 and amphiregulin (AREG) levels in chronic rhinosinusitis with nasal polyp , 2019, European Archives of Oto-Rhino-Laryngology.

[4]  Y. Gon,et al.  Expression of IL-25, IL-33, and Thymic Stromal Lymphopoietin in Nasal Polyp Gland Duct Epithelium in Patients With Chronic Rhinosinusitis , 2019, American journal of rhinology & allergy.

[5]  Jinfang Zhu,et al.  Orchestration between ILC2s and Th2 cells in shaping type 2 immune responses , 2019, Cellular & Molecular Immunology.

[6]  M. Kohanski,et al.  Sentinels at the wall: epithelial‐derived cytokines serve as triggers of upper airway type 2 inflammation , 2018, International forum of allergy & rhinology.

[7]  Zheng Liu,et al.  Pathophysiologic mechanisms of chronic rhinosinusitis and their roles in emerging disease endotypes. , 2019, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[8]  Yan Li,et al.  Bronchial Allergen Challenge of Patients with Atopic Asthma Triggers an Alarmin (IL-33, TSLP, and IL-25) Response in the Airways Epithelium and Submucosa , 2018, The Journal of Immunology.

[9]  G. Canonica,et al.  Immunological mechanisms underlying chronic rhinosinusitis with nasal polyps , 2018, Expert review of clinical immunology.

[10]  D. Riches,et al.  Overview of Innate Lung Immunity and Inflammation. , 2018, Methods in molecular biology.

[11]  L. Borish,et al.  Chronic rhinosinusitis: Endotypes, biomarkers, and treatment response , 2017, The Journal of allergy and clinical immunology.

[12]  D. Voehringer,et al.  Interactions between Innate Lymphoid Cells and Cells of the Innate and Adaptive Immune System , 2017, Front. Immunol..

[13]  A. Peters,et al.  Classical complement pathway activation in the nasal tissue of patients with chronic rhinosinusitis , 2017, The Journal of allergy and clinical immunology.

[14]  B. Tan,et al.  Acquired Immunity in Chronic Rhinosinusitis , 2017, Current Allergy and Asthma Reports.

[15]  Dae Woo Kim,et al.  Emerging Endotypes of Chronic Rhinosinusitis and Its Application to Precision Medicine , 2017, Allergy, asthma & immunology research.

[16]  A. Peters,et al.  Group 2 innate lymphoid cells are elevated and activated in chronic rhinosinusitis with nasal polyps , 2017, Immunity, inflammation and disease.

[17]  Sohee Oh,et al.  The role of interleukin-33 in chronic rhinosinusitis , 2016, Thorax.

[18]  C. Bachert,et al.  Diversity of TH cytokine profiles in patients with chronic rhinosinusitis: A multicenter study in Europe, Asia, and Oceania. , 2016, The Journal of allergy and clinical immunology.

[19]  N. Cohen,et al.  New insights into upper airway innate immunity , 2016, American journal of rhinology & allergy.

[20]  S. Durham,et al.  IL-25/IL-33–responsive TH2 cells characterize nasal polyps with a default TH17 signature in nasal mucosa , 2016, The Journal of allergy and clinical immunology.

[21]  M. Wagenmann,et al.  Cytokine Patterns and Endotypes in Acute and Chronic Rhinosinusitis , 2015, Current Allergy and Asthma Reports.

[22]  A. Peters,et al.  Elevated presence of myeloid dendritic cells in nasal polyps of patients with chronic rhinosinusitis , 2015, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[23]  R. Schleimer,et al.  Pathogenesis of nasal polyposis , 2015, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[24]  K. Hulse Immune Mechanisms of Chronic Rhinosinusitis , 2015, Current Allergy and Asthma Reports.

[25]  C. Bachert,et al.  Mixed T Helper Cell Signatures In Chronic Rhinosinusitis with and without Polyps , 2014, PloS one.

[26]  A. Peters,et al.  Basophils are elevated in nasal polyps of patients with chronic rhinosinusitis without aspirin sensitivity. , 2014, The Journal of allergy and clinical immunology.

[27]  A. Peters,et al.  Thymic stromal lymphopoietin activity is increased in nasal polyps of patients with chronic rhinosinusitis. , 2013, The Journal of allergy and clinical immunology.

[28]  A. Peters,et al.  Chronic rhinosinusitis with nasal polyps is characterized by B-cell inflammation and EBV-induced protein 2 expression. , 2013, The Journal of allergy and clinical immunology.

[29]  C. Bachert,et al.  Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma. , 2012, The Journal of allergy and clinical immunology.

[30]  C. Akdis,et al.  Defective epithelial barrier in chronic rhinosinusitis: the regulation of tight junctions by IFN-γ and IL-4. , 2012, The Journal of allergy and clinical immunology.

[31]  A. Peters,et al.  Evidence for intranasal antinuclear autoantibodies in patients with chronic rhinosinusitis with nasal polyps. , 2011, The Journal of allergy and clinical immunology.

[32]  C. Bachert,et al.  Differentiation of chronic sinus diseases by measurement of inflammatory mediators , 2006, Allergy.